Shanghai Henlius Biotech (HKSE:02696) Cash from Discontinued Operating Activities : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Henlius Biotech Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Shanghai Henlius Biotech's Cash from Discontinued Operating Activities for the three months ended in Dec. 2023 was HK$0 Mil. It means Shanghai Henlius Biotech received HK$0 Mil from discontinued investing activities. Shanghai Henlius Biotech's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0 Mil.

Shanghai Henlius Biotech Cash from Discontinued Operating Activities Historical Data

The historical data trend for Shanghai Henlius Biotech's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Henlius Biotech Cash from Discontinued Operating Activities Chart

Shanghai Henlius Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash from Discontinued Operating Activities

Get a 7-Day Free Trial

Shanghai Henlius Biotech Quarterly Data
	Dec17	Mar18	Jun18	Dec18	Mar19	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Cash from Discontinued Operating Activities	Get a 7-Day Free Trial												-	-	-	-	-

Shanghai Henlius Biotech Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

Shanghai Henlius Biotech Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Shanghai Henlius Biotech's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Henlius Biotech (HKSE:02696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Henlius Biotech Inc (HKSE:02696) » Definitions » Cash from Discontinued Operating Activities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1801 Hongmei Road, 9th Floor, Innov Tower (Capitaland Building), Xuhui District, Shanghai, CHN, 200233

Website

https://www.henlius.com

Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and innovative biologics for patients with a focus on oncology and autoimmune diseases. The Group is engaged in biopharmaceutical R&D, biopharmaceutical services, and biopharmaceutical production and sales. It operates in Mainland China and Overseas. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others.

Shanghai Henlius Biotech (HKSE:02696) Headlines

No Headlines